|
Type of medicine: Medicines containing chemical active substances
|
|
Therapeutic area: Bacterial Infections and Mycoses [C01]
|
| Brands: Please see report, Please see report, Please see report, Please see report, Please see report |
| MAH holders: Please see report, Please see report, Please see report |
| Assessment: |
| Active substance: CLARITHROMYCIN |
| ATC code: |
| Document link:
clarithromycin-aca-grec-2001.pdf
|
|
Document date: 2013-07-24
|
| Study number: ACA-GREC-2001-06 Synopsis |
|
EudraCT number:
|
| Scope of study: Clinical |
|
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
|
-
|
-
|
-
|
Y
|
Y
|